Nations Financial Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,624
Closed -$441K 351
2020
Q4
$441K Sell
2,624
-165
-6% -$26.8K 0.12% 213
2020
Q3
$439K Buy
+2,789
New +$456K 0.14% 186
2020
Q1
Sell
-1,718
Closed -$256K 269
2019
Q4
$256K Sell
1,718
-8,781
-84% -$1.21M 0.09% 255
2019
Q3
$1.36M Sell
10,499
-292
-3% -$38.9K 0.49% 45
2019
Q2
$1.52M Buy
10,791
+76
+0.7% +$10.5K 1% 19
2019
Q1
$1.62M Buy
10,715
+971
+10% +$140K 1.11% 17
2018
Q4
$1.21M Buy
9,744
+147
+2% +$20.1K 0.97% 22
2018
Q3
$1.52M Buy
9,597
+1,671
+21% +$253K 1.09% 18
2018
Q2
$1.11M Buy
+7,926
New +$1.09M 0.93% 19

Other funds holding FBT

Nations Financial Group's FBT Position: Q1 2021 in Review

Nations Financial Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2021, closing a stake of 2,624 shares — an estimated $441K sold.

Nations Financial Group first reported a position in FBT in Q2 2018 and held it in 9 quarters. The position peaked at $1.62M in Q1 2019. 235 funds tracked by Wall St. Rank hold FBT as of Q1 2021.

  • Nations Financial Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2021 after selling out during the quarter.
  • Nations Financial Group sold 2,624 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2021, an estimated $441K.
  • Nations Financial Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and held it in 9 quarters.
  • Nations Financial Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.62M in Q1 2019.
  • 235 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2021.

Based on Nations Financial Group's 13F filing for Q1 2021, filed 14 May 2021.